Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Evaluation of Residual Urine After Intermittent Catheterisation
This study has been completed.
Sponsored by: Coloplast A/S
Information provided by: Coloplast A/S
ClinicalTrials.gov Identifier: NCT00324233
  Purpose

Intermittent catheterization is a well-known method used for emptying the bladder. The objective of this study is to compare the residual urine after intermittent catheterisation with 2 different, hydrophilic coated, intermittent catheters. The study is a randomized, single blinded, crossover study including 24 healthy males.


Condition Intervention
Healthy
Device: Intermittent catheter

MedlinePlus related topics: Urine and Urination
U.S. FDA Resources
Study Type: Interventional
Study Design: Randomized, Single Blind, Active Control, Crossover Assignment, Safety/Efficacy Study
Official Title: Evaluation of Residual Urine After Intermittent Catheterisation – Comparison of 2 Hydrophilic Coated, Intermittent Catheters

Further study details as provided by Coloplast A/S:

Primary Outcome Measures:
  • Residual urine measured by ultra sound

Secondary Outcome Measures:
  • Hematuria measured by urine multi-dipstick
  • Subjectively measured discomfort
  • Subjectively measured handling
  • Subjectively measured insertion of the catheter

Estimated Enrollment: 24
Study Start Date: April 2006
Estimated Study Completion Date: June 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male
  • 18 years and above
  • A negative urine dip-stick
  • Have signed informed written consent to participate

Exclusion Criteria:

  • The test participant has previous or current congenital deformity, diseases or operation in the lower urinary tract
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00324233

Locations
Denmark, København Ø
Rigshospitalet
Copenhagen, København Ø, Denmark, 2100
Sponsors and Collaborators
Coloplast A/S
Investigators
Principal Investigator: Per Bagi, MD Rigshospitalet, Denmark
  More Information

Study ID Numbers: DK052CC
Study First Received: May 9, 2006
Last Updated: May 25, 2007
ClinicalTrials.gov Identifier: NCT00324233  
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics

Keywords provided by Coloplast A/S:
Residual urine
Hematuria
Ultra sound

Study placed in the following topic categories:
Hematuria
Healthy

ClinicalTrials.gov processed this record on January 16, 2009